J P Langeveld
Overview
Explore the profile of J P Langeveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meloen R, Langeveld J, Schaaper W, Slootstra J
Biologicals
. 2002 Feb;
29(3-4):233-6.
PMID: 11851321
In the early eighties it was realized that the ultimate vaccine would be a synthetic peptide. Major efforts were put into the development of a synthetic vaccine for foot-and-mouth disease...
2.
Beekman N, Schaaper W, Langeveld J, Boshuizen R, Meloen R
J Pept Res
. 2001 Sep;
58(3):237-45.
PMID: 11576330
The influence of the nature of the bond between a peptide and a (lipidic) carrier molecule on the immunogenicity of that construct was investigated. As types of bonds a thioester-,...
3.
Langeveld J, Brennan F, Martinez-Torrecuadrada J, Jones T, Boshuizen R, Vela C, et al.
Vaccine
. 2001 Jun;
19(27):3661-70.
PMID: 11395200
A vaccine based upon a recombinant plant virus (CPMV-PARVO1), displaying a peptide derived from the VP2 capsid protein of canine parvovirus (CPV), has previously been described. To date, studies with...
4.
Lauterslager T, Florack D, van der Wal T, Molthoff J, Langeveld J, Bosch D, et al.
Vaccine
. 2001 Mar;
19(17-19):2749-55.
PMID: 11257419
The efficacy of edible vaccines produced in potato tubers was examined in mice. Transgenic plants were developed by Agrobacterium tumefaciens-mediated transformation. The antigen selected was the non-toxic B subunit of...
5.
Langeveld J, Boshuizen R, Meloen R, Casal J
Vaccine
. 2001 Mar;
19(17-19):2352-60.
PMID: 11257360
Monoclonal antibody 3C9 was the starting material in the definition of the epitope that led to the synthesis of the first efficient peptide vaccine against a viral disease (canine parvovirus)...
6.
van Keulen L, Schreuder B, Vromans M, Langeveld J, Smits M
Arch Virol Suppl
. 2001 Feb;
(16):57-71.
PMID: 11214935
Although scrapie has been known for a long time as a natural disease of sheep and goats, the pathogenesis in its natural host still remains unclear. To study the pathogenesis...
7.
Rueda P, Fominaya J, Langeveld J, Bruschke C, Vela C, Casal J
Vaccine
. 2000 Dec;
19(7-8):726-34.
PMID: 11115693
We have demonstrated earlier the usefulness of recombinant porcine parvovirus (PPV) virus-like particles (VLPs) as an efficient recombinant vaccine for PPV. Here, we have demonstrated that preparations of PPV VLPs...
8.
Haik S, Peyrin J, Lins L, Rosseneu M, Brasseur R, Langeveld J, et al.
Neurobiol Dis
. 2000 Dec;
7(6 Pt B):644-56.
PMID: 11114262
It has been shown recently that the generation of an abnormal transmembrane form of the prion protein ((Ctm)PrP) is involved in the neurodegeneration process during inherited and infectious prion diseases...
9.
van Keulen L, Langeveld J, Garssen G, Jacobs J, Schreuder B, Smits M
Vet Q
. 2000 Nov;
22(4):197-200.
PMID: 11087129
Cows affected with bovine spongiform encephalopathy (BSE) display chronic neurological signs consisting of behavioural changes, abnormalities of posture and movement, and/or hyperaesthesia. At present, there are no laboratory test available...
10.
Rijsewijk F, Kaashoek M, Langeveld J, Maris-Veldhuis M, Magdalena J, Verschuren S, et al.
Arch Virol
. 2000 Jul;
145(5):921-36.
PMID: 10881679
Glycoprotein E (gE) of bovine herpesvirus 1 (BHV1) forms a complex with glycoprotein I (gI) and plays an important role in cell-to-cell spread mechanisms of the virus, but is not...